Quarterback 2:A Phase II Clinical Trial of Sequential Therapy and De-Intensified Chemoradiotherapy for Locally Advanced HPV Positive Oropharynx Cancer

ID Number 16-0609

Principal Investigator(s)
Marshall Posner

Department(s) or Division(s)
Hematology and Medical Oncology


The purpose of this study is to establish whether a lower dose radiation therapy given with weekly chemotherapy in patients with locally advanced HPV+ oropharynx cancer is as effective with fewer side effects compared to the higher standard dose, and find markers that would help select patients for this reduced treatment in the future.

Contact Information
Elizabeth Roy
(212) 824-7309

Recruiting Patients: Yes